Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

Finasteride effectively treats baldness but may cause sexual side effects.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The document concludes that hair follicles have a complex environment and our understanding of it is growing, but there are limitations when applying animal study findings to humans.

Too much epidermal growth factor can cause hair loss.

A man lost a lot of scalp hair quickly after stopping minoxidil, but it grew back with mild male pattern baldness.

Wnt signaling is crucial for skin development and hair growth.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Intradermotherapy with minoxidil is as effective as topical application for treating hair loss.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Effective treatments for severe alopecia areata are still lacking.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.